|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.85 CNY | +0.25% |
|
-3.41% | +4.97% |
| Dec. 17 | Sansure Biotech Gets China Nod for Four Testing Kits | MT |
| Nov. 03 | Sansure Biotech Gets Registration Certificates for Pathogen Detection Kits | MT |
| Capitalization | 11.37B 1.63B 1.39B 1.29B 1.21B 2.25B 149B 2.39B 14.71B 5.83B 70.54B 6.11B 5.99B 258B | P/E ratio 2025 * |
33.9x | P/E ratio 2026 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise value | 11.37B 1.63B 1.39B 1.29B 1.21B 2.25B 149B 2.39B 14.71B 5.83B 70.54B 6.11B 5.99B 258B | EV / Sales 2025 * |
5.98x | EV / Sales 2026 * | 4.89x |
| Free-Float |
46.07% | Yield 2025 * |
2.63% | Yield 2026 * | 2.63% |
| 1 day | +0.25% | ||
| 1 week | -3.41% | ||
| Current month | +4.97% | ||
| 1 month | +3.49% | ||
| 3 months | -2.36% | ||
| 6 months | -7.33% | ||
| Current year | +4.97% |
| 1 week | 19.62 |  | 20.3 |
| 1 month | 18.8 | | 21.36 |
| Current year | 18.89 | | 21.36 |
| 1 year | 17.73 | | 26.36 |
| 3 years | 14.72 | | 26.36 |
| 5 years | 14.72 | | 97.05 |
| 10 years | 14.72 | | 105.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Zhong Dai
CEO | Chief Executive Officer | 58 | 2019-07-07 |
Wu Tan
IRC | Investor Relations Contact | 42 | - |
Zhu Peng
DFI | Director of Finance/CFO | 50 | 2019-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Li Zhong Dai
CHM | Chairman | 58 | 2008-04-22 |
Xia Lin Yu
BRD | Director/Board Member | 47 | - |
Zhu Peng
BRD | Director/Board Member | 50 | 2020-02-21 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +16.06% | 1.04% | 6 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.25% | -3.41% | -1.15% | -14.18% | 1.63B | |
| +3.02% | +6.72% | +153.18% | +253.97% | 14.91B | |
| +0.19% | -1.51% | -6.94% | +7.04% | 14.42B | |
| +2.14% | -3.13% | - | - | 7.19B | |
| -0.51% | -4.12% | -8.77% | +1.11% | 6.41B | |
| -0.08% | -3.24% | -30.38% | -41.32% | 4.64B | |
| +1.10% | +3.06% | -29.32% | +23.50% | 4.41B | |
| +0.05% | -1.29% | -8.13% | -43.70% | 3.02B | |
| +2.18% | +9.34% | +42.12% | -51.63% | 2.87B | |
| Average | +0.94% | +0.38% | +13.83% | +16.85% | 6.61B | |
| Weighted average by Cap. | +1.24% | +0.38% | +37.32% | +66.99% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.9B 272M 232M 215M 202M 376M 24.96B 399M 2.46B 974M 11.79B 1.02B 1B 43.14B | 2.32B 333M 284M 263M 247M 460M 30.52B 487M 3.01B 1.19B 14.41B 1.25B 1.22B 52.75B |
| Net income | 338M 48.48M 41.26M 38.32M 35.93M 66.9M 4.44B 70.92M 437M 173M 2.1B 182M 178M 7.67B | 434M 62.29M 53.02M 49.24M 46.16M 85.96M 5.71B 91.14M 562M 223M 2.7B 234M 229M 9.86B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-21 | 19.85 ¥ | +0.25% | 4,026,492 |
| 26-01-21 | 19.80 ¥ | +0.20% | 5,301,091 |
| 26-01-20 | 19.76 ¥ | -0.45% | 4,692,717 |
| 26-01-19 | 19.85 ¥ | -0.40% | 4,827,966 |
| 26-01-16 | 19.93 ¥ | -1.14% | 5,539,035 |
End-of-day quote Shanghai S.E., January 21, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688289 Stock
Select your edition
All financial news and data tailored to specific country editions
